193 related articles for article (PubMed ID: 27518436)
1. Caspase-2 deficiency accelerates chemically induced liver cancer in mice.
Shalini S; Nikolic A; Wilson CH; Puccini J; Sladojevic N; Finnie J; Dorstyn L; Kumar S
Cell Death Differ; 2016 Oct; 23(10):1727-36. PubMed ID: 27518436
[TBL] [Abstract][Full Text] [Related]
2. Caspase-3 suppresses diethylnitrosamine-induced hepatocyte death, compensatory proliferation and hepatocarcinogenesis through inhibiting p38 activation.
Shang N; Bank T; Ding X; Breslin P; Li J; Shi B; Qiu W
Cell Death Dis; 2018 May; 9(5):558. PubMed ID: 29752472
[TBL] [Abstract][Full Text] [Related]
3. DJ-1 promotes development of DEN-induced hepatocellular carcinoma and proliferation of liver cancer cells.
Qiu B; Wang J; Yu Y; Zhen C; Gu J; Liu W; Wen Y; Chen L; Gao Y; Xia Q; Kong X
Oncotarget; 2017 Jan; 8(5):8499-8511. PubMed ID: 28036277
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-17A Plays a Pivotal Role in Chemically Induced Hepatocellular Carcinoma in Mice.
Sun C; Kono H; Furuya S; Hara M; Hirayama K; Akazawa Y; Nakata Y; Fujii H
Dig Dis Sci; 2016 Feb; 61(2):474-88. PubMed ID: 26467699
[TBL] [Abstract][Full Text] [Related]
5. Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.
Schneider C; Teufel A; Yevsa T; Staib F; Hohmeyer A; Walenda G; Zimmermann HW; Vucur M; Huss S; Gassler N; Wasmuth HE; Lira SA; Zender L; Luedde T; Trautwein C; Tacke F
Gut; 2012 Dec; 61(12):1733-43. PubMed ID: 22267597
[TBL] [Abstract][Full Text] [Related]
6. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
[TBL] [Abstract][Full Text] [Related]
7. Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation.
Sakurai T; Maeda S; Chang L; Karin M
Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10544-51. PubMed ID: 16807293
[TBL] [Abstract][Full Text] [Related]
8. Defective apoptotic cell contractility provokes sterile inflammation, leading to liver damage and tumour suppression.
Julian L; Naylor G; Wickman GR; Rath N; Castino G; Stevenson D; Bryson S; Munro J; McGarry L; Mullin M; Rice A; Del Río Hernández A; Olson MF
Elife; 2021 Apr; 10():. PubMed ID: 33871359
[TBL] [Abstract][Full Text] [Related]
9. Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice.
Lin H; Yan J; Wang Z; Hua F; Yu J; Sun W; Li K; Liu H; Yang H; Lv Q; Xue J; Hu ZW
Hepatology; 2013 Jan; 57(1):171-82. PubMed ID: 22859216
[TBL] [Abstract][Full Text] [Related]
10. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
Chung YL; Wu ML
J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
[TBL] [Abstract][Full Text] [Related]
11. Defective DNA strand break repair causes chromosomal instability and accelerates liver carcinogenesis in mice.
Teoh NC; Dan YY; Swisshelm K; Lehman S; Wright JH; Haque J; Gu Y; Fausto N
Hepatology; 2008 Jun; 47(6):2078-88. PubMed ID: 18506893
[TBL] [Abstract][Full Text] [Related]
12. Lack of gp130 expression in hepatocytes attenuates tumor progression in the DEN model.
Hatting M; Spannbauer M; Peng J; Al Masaoudi M; Sellge G; Nevzorova YA; Gassler N; Liedtke C; Cubero FJ; Trautwein C
Cell Death Dis; 2015 Mar; 6(3):e1667. PubMed ID: 25741592
[TBL] [Abstract][Full Text] [Related]
13. A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer Development.
Boege Y; Malehmir M; Healy ME; Bettermann K; Lorentzen A; Vucur M; Ahuja AK; Böhm F; Mertens JC; Shimizu Y; Frick L; Remouchamps C; Mutreja K; Kähne T; Sundaravinayagam D; Wolf MJ; Rehrauer H; Koppe C; Speicher T; Padrissa-Altés S; Maire R; Schattenberg JM; Jeong JS; Liu L; Zwirner S; Boger R; Hüser N; Davis RJ; Müllhaupt B; Moch H; Schulze-Bergkamen H; Clavien PA; Werner S; Borsig L; Luther SA; Jost PJ; Weinlich R; Unger K; Behrens A; Hillert L; Dillon C; Di Virgilio M; Wallach D; Dejardin E; Zender L; Naumann M; Walczak H; Green DR; Lopes M; Lavrik I; Luedde T; Heikenwalder M; Weber A
Cancer Cell; 2017 Sep; 32(3):342-359.e10. PubMed ID: 28898696
[TBL] [Abstract][Full Text] [Related]
14. The matricellular protein CCN1 suppresses hepatocarcinogenesis by inhibiting compensatory proliferation.
Chen CC; Kim KH; Lau LF
Oncogene; 2016 Mar; 35(10):1314-23. PubMed ID: 26028023
[TBL] [Abstract][Full Text] [Related]
15. Influence of sex and developmental stage on acute hepatotoxic and inflammatory responses to liver procarcinogens in the mouse.
Hanna D; Riedmaier AE; Sugamori KS; Grant DM
Toxicology; 2016 Dec; 373():30-40. PubMed ID: 27746196
[TBL] [Abstract][Full Text] [Related]
16. Sequential analysis and staging of a diethylnitrosamine-induced hepatocellular carcinoma in male Wistar albino rat model.
Fathy AH; Bashandy MA; Bashandy SAE; Mansour AM; Elsadek B
Can J Physiol Pharmacol; 2017 Dec; 95(12):1462-1472. PubMed ID: 28854340
[TBL] [Abstract][Full Text] [Related]
17. N-diethylnitrosamine mouse hepatotoxicity: time-related effects on histology and oxidative stress.
Paula Santos N; Colaço A; Gil da Costa RM; Manuel Oliveira M; Peixoto F; Alexandra Oliveira P
Exp Toxicol Pathol; 2014 Dec; 66(9-10):429-36. PubMed ID: 25097018
[TBL] [Abstract][Full Text] [Related]
18. Higher CYP2E1 Activity Correlates with Hepatocarcinogenesis Induced by Diethylnitrosamine.
Gao J; Wang Z; Wang GJ; Zhang HX; Gao N; Wang J; Wang CE; Chang Z; Fang Y; Zhang YF; Zhou J; Jin H; Qiao HL
J Pharmacol Exp Ther; 2018 May; 365(2):398-407. PubMed ID: 29467309
[TBL] [Abstract][Full Text] [Related]
19. Constitutive Notch2 signaling induces hepatic tumors in mice.
Dill MT; Tornillo L; Fritzius T; Terracciano L; Semela D; Bettler B; Heim MH; Tchorz JS
Hepatology; 2013 Apr; 57(4):1607-19. PubMed ID: 23175466
[TBL] [Abstract][Full Text] [Related]
20. Diethylnitrosamine Increases Proliferation in Early Stages of Hepatic Carcinogenesis in Insulin-Treated Type 1 Diabetic Mice.
Arboatti AS; Lambertucci F; Sedlmeier MG; Pisani G; Monti J; Álvarez ML; Francés DEA; Ronco MT; Carnovale CE
Biomed Res Int; 2018; 2018():9472939. PubMed ID: 29850590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
